Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning
Yifan Yu, Zeyan Xu, Zejun Zhu, Jiayi Liao, Xu Huang, Kexin Chen, Zaiyi Liu, Ying Wang, Changhong Liang, Lei Wu · 2026
Read Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning by Yifan Yu, Zeyan Xu, Zejun Zhu, Jiayi Liao, Xu Huang, Kexin Chen, Zaiyi Liu, Ying Wang, Changhong Liang, Lei Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13639070.txt.
Description
Yifan Yu and nine colleagues present a 2026 deep learning model that predicts recurrence risk in early-stage breast cancer from scans plus clinical notes. Judging who needs added therapy after surgery remains difficult, and relapse still drives most deaths from this cancer.
Their multimodal model combined two kinds of MRI with text records for 1,120 patients across several hospitals. It forecast disease-free survival with solid accuracy in both training and outside groups. Patients with low model scores gained clear benefit from adjuvant therapy, while those with high scores did not. The tool could help doctors match treatment intensity to personal risk.
Catalog record
| CREATOR | Yifan Yu, Zeyan Xu, Zejun Zhu, Jiayi Liao, Xu Huang, Kexin Chen, Zaiyi Liu, Ying Wang, Changhong Liang, Lei Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56612 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |